News & Updates

Infants conceived with the help of infertility treatments, such as ovulation induction (OI) and artificial insemination with the husband’s sperm (AIH), are more likely to experience developmental delays at 2 years of age, according to a recent Japan study. However, such delays appear to grow nonsignificant by 3.5 years of age.

Crohn’s disease (CD) remission, induced by either CD exclusion diet with partial enteral nutrition (CDED+PEN) or by exclusive enteral nutrition (EEN), leads to significant changes in metabolite levels in paediatric patients, according to a new study.

Elevated levels of sialylated human milk oligosaccharides (HMO) in mothers’ breastmilk appears to worsen infant nutritional status, reports a Bangladesh study.

New drug applications approved by US FDA as of 01 - 15 June 2022 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.

The use of pranlukast in infants with respiratory syncytial virus (RSV) infections appears to help avoid the need for respiratory support, a recent Japan study has found.

Exposure to phthalates while still in the womb is associated with lower body mass index (BMI) z-scores in children, suggesting impaired growth, reports a recent meta-analysis. Prenatal exposure, on the other hand, does not seem to affect body fat percentage.

Risk prediction models including factors such as maternal smoking status, body mass index, and parity, can help predict small-for-gestational age (SGA) during pregnancy, a recent Japan study has found.